Successful unrelated cord blood transplantation for Epstein-Barr virus-associated lymphoproliferative disease with hemophagocytic syndrome.

Abstract:

:We report a case of successful umbilical cord blood transplantation (CBT) for Epstein-Barr virus (EBV)-associated lymphoproliferative disease (LPD) in a 6-year-old girl. The patient had hemophagocytic syndrome with excessive circulating levels of EBV DNA that was refractory to immunochemotherapy. Multiple hepatosplenic lesions favored the diagnosis of EBV-associated LPD, although the aggressive course precluded the histopathologic diagnosis. Unrelated CB cells mismatched at 1 HLA locus were infused after patient conditioning with 900 mg/m2 etoposide, 2 g/m2 cytarabine, 16 mg/kg busulfan, and 200 mg/kg cyclophosphamide. Complete chimeric status was obtained on day 19 posttransplantation. Drug fever and acute graft-versus-host disease of the skin (grade II) were the major complications. A transient increase of EBV DNA 1 year after CBT indicated a primary EBV infection of the donor cells. The patient is alive with no evidence of disease 27 months after CBT. There has been no previous report of successful CBT for EBV-related LPD/lymphoma. CBT can be a curative treatment for the disease, even if no viral memory has been set in the stem cell source.

journal_name

Int J Hematol

authors

Toubo T,Suga N,Ohga S,Nomura A,Onoe Y,Takada H,Hara T

doi

10.1532/ijh97.04081

subject

Has Abstract

pub_date

2004-12-01 00:00:00

pages

458-62

issue

5

eissn

0925-5710

issn

1865-3774

journal_volume

80

pub_type

杂志文章
  • Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.

    abstract::TAL1/SCL is a prime example of an oncogenic transcription factor that is abnormally expressed in acute leukemia due to the replacement of regulator elements. This gene has also been recognized as an essential regulator of hematopoiesis. TAL1 expression is strictly regulated in a lineage- and stage-specific manner. Suc...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/s12185-018-2518-z

    authors: Tan TK,Zhang C,Sanda T

    更新日期:2019-01-01 00:00:00

  • Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation.

    abstract::Bronchiolitis obliterans (BO) after allogeneic stem cell transplantation (allo-SCT) is a late-onset, life-threatening respiratory complication that significantly reduces a patient's quality of life. We retrospectively analysed the incidence of and risk factors for BO in allo-SCT recipients. In 2087 patients who underw...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-011-0809-8

    authors: Nakaseko C,Ozawa S,Sakaida E,Sakai M,Kanda Y,Oshima K,Kurokawa M,Takahashi S,Ooi J,Shimizu T,Yokota A,Yoshiba F,Fujimaki K,Kanamori H,Sakai R,Saitoh T,Sakura T,Maruta A,Sakamaki H,Okamoto S

    更新日期:2011-03-01 00:00:00

  • Successful treatment with bortezomib in type-1 cryoglobulinemic vasculitis patient after rituximab failure: a case report and literature review.

    abstract::Type-1 cryoglobulinemic vasculitis (CV) and mixed CV differ in their pathophysiology, clinical expression and treatment response. We report one patient with type-1 cryoglobulinemic vasculitis and skin ulcers that had remained active despite treatment with a variety of immunomodulating drugs including rituximab. The pa...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/s12185-013-1323-y

    authors: Besada E,Vik A,Koldingsnes W,Nossent JC

    更新日期:2013-06-01 00:00:00

  • Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?

    abstract::Severe hyperlipidaemia with asparaginase therapy is rare. We report six cases, four of which developed significant problems with severe hyperlipidaemia during induction therapy for ALL and lymphoblastic lymphoma. The median triglyceride level was 22.3 mmol/L and the median cholesterol level was 12.3 mmol/L. None of th...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-011-0966-9

    authors: Lashkari HP,Lancaster D,Atra A,Champion MP,Taj MM

    更新日期:2011-12-01 00:00:00

  • The end is just the beginning: megakaryocyte apoptosis and platelet release.

    abstract::Under influence of hematopoietic growth factors, particularly thrombopoietin (TPO), hematopoietic stem cells in the bone marrow go through a process of commitment, proliferation, differentiation, and maturation and become mature megakaryocytes. At this critical point, terminally differentiated megakaryocytes face a ne...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/BF02982078

    authors: Li J,Kuter DJ

    更新日期:2001-12-01 00:00:00

  • Two patients with all-trans retinoic acid-resistant acute promyelocytic leukemia treated successfully with gemtuzumab ozogamicin as a single agent.

    abstract::Acute promyelocytic leukemia (APL) cells express a considerable level of CD33, which is the target of gemtuzumab ozogamicin (GO), and a significantly lower level of P-glycoprotein (P-gp). Therefore, GO is predicted to be a successful treatment for APL. In this article, we report on the GO treatment of 2 patients with ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1532/IJH97.05069

    authors: Takeshita A,Shinjo K,Naito K,Matsui H,Sahara N,Shigeno K,Suzumura T,Horii T,Shirai N,Maekawa M,Yada Y,Teshima H,Takeuchi J,Ohnishi K,Ohno R

    更新日期:2005-12-01 00:00:00

  • Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma.

    abstract::Therapeutic strategies for early-stage diffuse large B-cell lymphoma (DLBCL) are often influenced by tumor extent, but the prognostic value of this parameter is rarely defined. Here, a retrospective analysis was performed to define the impact of tumor extent on survival of patients with early-stage DLBCL. Eighty-six p...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-013-1260-9

    authors: Yoo C,Yoon DH,Kim JE,Jo J,Park SJ,Yoon SK,Ahn Y,Kim S,Huh J,Lee DH,Suh C

    更新日期:2013-02-01 00:00:00

  • Lung injury associated with bortezomib therapy in relapsed/refractory multiple myeloma in Japan: a questionnaire-based report from the "lung injury by bortezomib" joint committee of the Japanese society of hematology and the Japanese society of clinical h

    abstract::Bortezomib is a proteasome inhibitor that can be effective in the treatment of refractory and relapsed multiple myeloma. Recently, severe pulmonary complications associated with bortezomib therapy have been reported in Japan. Because bortezomib has not yet been approved for general use in Japan and is imported by atte...

    journal_title:International journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1532/IJH97.06142

    authors: Gotoh A,Ohyashiki K,Oshimi K,Usui N,Hotta T,Dan K,Ikeda Y

    更新日期:2006-12-01 00:00:00

  • Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses.

    abstract::We statistically analyzed the hematologic findings of patients with refractory anemia (RA) to identify parameters associated with a poor prognosis. We first separated the RA patients into two groups: one group with disease progression and one without. The patients with disease progression were predominantly male and h...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Iwabuchi A,Ohyashiki K,Ohyashiki JH,Kimura Y,Lin KY,Aizawa S,Nehashi Y,Miyazawa K,Yaguchi M,Toyama K

    更新日期:1994-10-01 00:00:00

  • Two case reports of inherited antithrombin deficiency: a novel frameshift mutation and a large deletion including all seven exons detected using two methods.

    abstract::An inherited antithrombin deficiency is an autosomal dominant thrombotic disorder. We identified two pedigrees of inherited type I antithrombin deficiency and two responsible mutations in each. A novel 21-22delAA appeared to have caused a frameshift with a premature termination at amino acid +63 in one patient and a l...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-010-0763-x

    authors: Sekiya A,Morishita E,Karato M,Maruyama K,Shimogawara I,Omote M,Wakugawa Y,Shinohara M,Hayashi T,Kadohira Y,Asakura H,Nakao S,Ohtake S

    更新日期:2011-02-01 00:00:00

  • A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma.

    abstract::Patients with aggressive adult T-cell leukemia-lymphoma (ATL) have dismal outcomes with intensive chemotherapy. Early up-front allogeneic hematopoietic stem cell transplantation (allo-HSCT) is generally recommended. However, the choice of stem cell source, i.e., unrelated bone marrow transplant (UBMT) or cord blood tr...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-019-02777-w

    authors: Fuji S,Kurosawa S,Inamoto Y,Murata T,Utsunomiya A,Uchimaru K,Yamasaki S,Inoue Y,Moriuchi Y,Choi I,Ogata M,Hidaka M,Yamaguchi T,Fukuda T

    更新日期:2020-03-01 00:00:00

  • Trend and treatment patterns of aplastic anemia in Korea, pure red cell aplasia and myelodysplastic syndrome in Korea: a nation-wide analysis.

    abstract::Aplastic anemia (AA) and pure red cell aplasia (PRCA) appear to be more prevalent in Asian countries including Korea. However, there are no exact data regarding its prevalence and frequency of allogeneic hematopoietic cell transplantation (HCT) in Korea. Here, we present demographic data relating to AA/PRCA/MDS in Kor...

    journal_title:International journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1007/s12185-017-2280-7

    authors: Choi Y,Jo JC,Jeon HJ,Kim DW,Chang MH,Kim H

    更新日期:2017-10-01 00:00:00

  • Current status of Japan marrow donor program (JMDP) and its roles in international cooperation.

    abstract::Transplants for patients lacking an HLA identical sibling donor have become possible, and thank to the establishment of large registries of HLA typed volunteers. Japan Marrow Donor Program (JMDP) now stands at about 152,339 volunteer donors, and have provided 4,013 marrows nationally and internationally. Advancements ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF03165270

    authors: Okamoto S

    更新日期:2002-08-01 00:00:00

  • The effect of phlebotomy on serum erythropoietin levels in normal healthy subjects.

    abstract::We evaluated endogenous serum erythropoietin (Epo) levels in 14 normal subjects (eight males and six females) after a single 400-ml phlebotomy. The subjects were followed up for 56 days. The hemoglobin (Hb) values of both males and females decreased to a nadir on days 3 to 7 post-phlebotomy. Hb values gradually increa...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Maeda H,Hitomi Y,Hirata R,Tohyama H,Suwata J,Kamata S,Fujino Y,Murata N

    更新日期:1992-04-01 00:00:00

  • Gamma/delta T-cell lymphoma with hepatosplenomegaly: report of a case.

    abstract::We describe the case of a patient with peripheral gamma/delta T-cell lymphoma (T-ML) with hepatosplenomegaly, generalized lymphadenopathy, and bone marrow involvement. A 44-year-old man had lymphoma, which became clinically apparent 2 months after the onset of myositis and insulin-dependent diabetes mellitus. A cervic...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Ohno T,Komada F,Yamaguchi M,Oka K,Nishii K,Tsuda M,Katsuta K,Yamaguchi T,Kita K,Shirakawa S

    更新日期:1993-06-01 00:00:00

  • Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.

    abstract::IKZF1 encodes a transcription factor involved in B-cell maturation and differentiation. We genotyped 218 diffuse large B-cell lymphoma (DLBCL) patients and 715 unrelated controls using a TaqMan allelic discrimination assay. No statistical difference was observed in the genotype distribution of the IKZF1 rs4132601 poly...

    journal_title:International journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s12185-017-2315-0

    authors: Bielska M,Borowiec M,Jesionek-Kupnicka D,Braun M,Bojo M,Pastorczak A,Kalinka-Warzocha E,Prochorec-Sobieszek M,Robak T,Warzocha K,Młynarski W,Lech-Marańda E

    更新日期:2017-12-01 00:00:00

  • DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

    abstract::DNA methylation provides a major epigenetic code (besides histone modification) of the lineage- and development-specific genes (such as regulators of differentiation in the hematopoietic lineages) that control expression of normal cells. However, DNA methylation is also involved in malignancies because aberrant methyl...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1532/ijh97.04094

    authors: Rüter B,Wijermans PW,Lübbert M

    更新日期:2004-08-01 00:00:00

  • Acquired sideroblastic anaemia induced by a copper-chelating agent.

    abstract::Acquired sideroblastic anaemia may be related to drugs and other chemicals that inhibit the activity of mitochondrial enzymes involved in haem synthesis. We report a case of secondary acquired sideroblastic anaemia following administration of triethylene tetramine dihydrochloride (trientine), a second-line copper-chel...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1016/0925-5710(96)00457-4

    authors: Perry AR,Pagliuca A,Fitzsimons EJ,Mufti GJ,Williams R

    更新日期:1996-07-01 00:00:00

  • Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection.

    abstract::The occurrence of chronic myeloid leukaemia (CML) in patients infected with the human immunodeficiency virus (HIV) has rarely been reported in the literature. In this report, we describe the experience of a single centre in the management of 10 such patients, including demographic information, disease characteristics ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-012-1073-2

    authors: Webb MJ,Barrett CL,Pretorius C,van Jaarsveld MF,Louw VJ

    更新日期:2012-05-01 00:00:00

  • A chronic myeloid leukemia patient with atypical karyotype and BCR-ABL e13a3 transcript caused by complex chromosome rearrangement.

    abstract::Philadelphia (Ph) chromosome as a result of t (9; 22) (q34; q11) is observed in more than 90% of chromic myeloid leukemia (CML) patients. Cases in which the typical Ph chromosome is not visible at the karyotype level comprise 5-10% of CML patients. CML cases with fusion transcripts such as e13a3 in which ABL exon 3 ra...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-009-0368-4

    authors: Masuko M,Furukawa T,Abe T,Wada R,Maruyama S,Kitajima T,Shibasaki Y,Toba K,Okada M,Aizawa Y

    更新日期:2009-09-01 00:00:00

  • Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia.

    abstract::The rare recurrent translocation of (8;9)(p22;p24) with PCM1-JAK2 fusion was recently characterized in diverse hematological malignancies. Most of them are atypical chronic myeloid leukemia (CML) or other myeloproliferative disorders (MPD), and are predominantly in the male. We report a female patient with acute myelo...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-008-0113-4

    authors: Huang KP,Chase AJ,Cross NCP,Reiter A,Li TY,Wang TF,Chu SC,Lu XY,Li CC,Kao RH

    更新日期:2008-09-01 00:00:00

  • Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis.

    abstract::von Willebrand factor (VWF) performs its hemostatic functions through binding to various proteins. The A1 domain of VWF contains binding sites of not only physiologically important ligands, but also exogenous modulators that induce VWF-platelet aggregation. Sulfatides, 3-sulfated galactosyl ceramides, that are express...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-008-0065-8

    authors: Nakayama T,Matsushita T,Yamamoto K,Mutsuga N,Kojima T,Katsumi A,Nakao N,Sadler JE,Naoe T,Saito H

    更新日期:2008-05-01 00:00:00

  • Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts.

    abstract::We evaluated the engraftment and the cell cycle status of marrow cells at various times after 5-fluorouracil (5-FU) administration. 5-FU (150 mg/kg) was given to donor male BALB/c mice at 1, 2, 6, or 12 days prior to marrow harvest. The donor cells were then assessed in host nonmyeloablated female mice. Bone marrow en...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02982554

    authors: D'Hondt L,Carlson J,Benoit B,Reilly J,Grimaldi C,Wuu J,Lambert JF,Dooner MS,Quesenberry PJ

    更新日期:2001-07-01 00:00:00

  • Diffuse follicular lymphoma variant with a typical diagnostic pattern and an unusually aggressive clinical presentation.

    abstract::Diffuse follicular lymphoma (FL) variant is a rare condition that shows distinctive clinical, morphological, immunophenotypic, and molecular features that distinguish it from classical FL. Diffuse FL variant is characterized by a predominantly diffuse growth pattern, absence of the t (14;18) IGH/BCL2 translocation, CD...

    journal_title:International journal of hematology

    pub_type: 信件

    doi:10.1007/s12185-020-02901-1

    authors: Martín-Moro F,Marquet-Palomanes J,Piris-Villaespesa M,Lopez-Jiménez J,García-Cosío M

    更新日期:2020-08-01 00:00:00

  • Clonality analysis of granulocytes and T lymphocytes in healthy females by the PCR-based HUMARA method.

    abstract::Clonality analysis utilizing X-chromosome inactivation has been used in the study of various diseases, including hematological malignancies. The human androgen receptor gene (HUMARA) assay is the newest of such methods, and the majority of the female population can be assessed by this relatively simple procedure. One ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Nakahara Y,Suzuki H,Ohashi H,Hatano S,Tomita A,Kinoshita T,Murate T,Saito H,Hotta T

    更新日期:1999-06-01 00:00:00

  • Ph1-positive acute lymphoblastic leukemia associated with an isochromosome 17q.

    abstract::We report a patient with Ph1-positive acute lymphoblastic leukemia (ALL) having i(17q) in whom bony lesions were the initial clinical manifestation. The patient was a 53-year-old male who began to have pains in his left hip early in March 1985. Relevant findings on admission included: WBC 21,300/microliters; blast cel...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:

    authors: Kageyama T,Takiuchi H,Hasegawa M,Ohyabu H,Horiike S

    更新日期:1991-06-01 00:00:00

  • Acute myeloid leukemia in older adults.

    abstract::Acute myeloid leukemia (AML) is predominantly a disease of older adults, with a median age at diagnosis of over 65 years. AML in older adults differs biologically and clinically from that in younger ones, and is characterized by stronger intrinsic resistance and lower tolerance to chemotherapy. The effects of age on b...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/s12185-012-1137-3

    authors: Yanada M,Naoe T

    更新日期:2012-08-01 00:00:00

  • Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.

    abstract::Osteonecrosis (ON) is a potentially disabling complication encountered in children who receive chemotherapy for acute lymphoblastic leukemia (ALL). Considering the possible effect of ethnic difference on the clinical features of symptomatic ON in pediatric ALL, we retrospectively evaluated 245 children with ALL who we...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-015-1790-4

    authors: Chen SH,Chang TY,Jaing TH,Lee MS,Wang CJ,Hung IJ,Yang CP

    更新日期:2015-07-01 00:00:00

  • Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.

    abstract::A.R.R.O.W. evaluated the superiority of once-weekly carfilzomib plus dexamethasone (Kd) 20/70 mg/m2 vs. twice-weekly Kd 20/27 mg/m2 based on progression-free survival (PFS) in relapsed and/or refractory multiple myeloma patients. Forty Japanese patients (once-weekly arm, n = 26; twice-weekly arm, n = 14) were randomiz...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-020-03013-6

    authors: Takezako N,Shibayama H,Handa H,Hagiwara S,Ozaki S,Suzuki K,Kosugi H,Ri M,Sugiura I,Choi I,Miyamoto T,Iida S

    更新日期:2020-10-10 00:00:00

  • CDNA microarray analysis of chronic myeloid leukemia.

    abstract::A series of expression microarray analyses of chronic myeloid leukemia (CML) by means of complementary DNA microarray representing a set of 1024 human genes were initiated to evaluate the role of expression microarray analysis in CML and to identify CML-associated genes. Among the target genes, 388 differentially expr...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02982130

    authors: Li H,Jie S,Zou P,Zou G

    更新日期:2002-05-01 00:00:00